In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IntegenX Inc.

www.integenx.com

Latest From IntegenX Inc.

Device and Diagnostics Dealmaking Quarterly Statistics, Q4 2011

Medical device companies raised $800 million in the fourth quarter of 2011, and venture capital represented half of that amount. Just over $4 billion was spent to acquire medical device companies, down 50% from Q3’s $8 billion. In vitro diagnostics/research financings were well above the previous quarter, raking in a total of $269 million, with late-stage rounds again bringing in most of the Q4 money. Only five M&A deals were completed, totalling $915 million – way down from Q3’s $2.8 billion for the same number of deals.

Medical Device Deals

On The Move: Who’s Going Where In Biopharma And Medtech Start-Ups

Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.

Recent Financings of Private Companies (01/2012)

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies within the in vitro diagnostics, pharmaceuticals, research/analytical equipment & supplies, and medical device sectors.

BioPharmaceutical Medical Device

Start-Up Previews (12/06)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Next-Generation Sequencing" includes profiles of BioNanomatrix, LaserGen, and Microchip Biotechnologies. Plus these Start-Ups Across Health Care: Althera, Impliant, Tenaxis, and VIDA Diagnostics.
See All

Company Information

  • Industry
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Microchip Biotechnologies Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • IntegenX Inc.
  • Senior Management
  • Stevan Jovanovich, PhD, Pres. & CEO
    Ezra Van Gelder, EVP, R&D
    Dennis Harris, PhD, CSO
    Howard D Goldstein, EVP, Commercial Affairs
  • Contact Info
  • IntegenX Inc.
    Phone: (925) 701-3400
    5720 Stoneridge Dr.
    Pleasanton, CA 94588
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register